Pearl Health, a healthcare technology company helping providers manage risk for Medicare patients, announced Wednesday that it secured $110 million in funding. The New York-based company supports ...

Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this space is the acquisition of CrossBridge Bio, a preclinical startup with ...

Negotiations between Mount Sinai Health System and Anthem Blue Cross Blue Shield collapsed this week, forcing the New York-based health system’s providers and services out of Anthem’s insurance ...

A rare autoimmune disease affecting the kidneys has a new FDA approved treatment, a first-in-class Vera Therapeutics drug whose approach of hitting two targets sets it apart from the medicines already ...

Lawsuits don’t often end in partnerships. And yet that is the strange but true tale involving Hims & Hers and drug manufacturer Novo Nordisk. Last month, Novo Nordisk sued Hims & Hers over its sale ...

For plaque psoriasis patients whose disease does not adequately respond to topical treatments, the next choice of therapies is typically injectable drugs. FDA approval of a Johnson & Johnson drug ...

Roughly 31,000 Kaiser Permanente nurses and other healthcare workers returned to work on Tuesday following a four-week strike. The strike ended because there has been significant movement at the ...

Mental health has become a defining priority in the modern workplace, particularly within the health care sector. Employee assistance programs (EAPs) provide confidential counseling, wellness ...

This month, the board of trustees for Williamson Health, a county-owned health system in Tennessee, voted unanimously to sell the organization to Ascension Saint Thomas, Ascension‘s Tennessee division ...

As value-based care and bundled payments begin to take hold in the orthopedics industry and healthcare overall, Kalamazoo, Michigan-based Stryker is doing something counterintuitive. It is launching ...

A rare, inherited endocrine disorder whose standard treatments are steroids that introduce a wide range of side effects now has a new FDA-approved therapy, a non-steroidal Neurocrine Biosciences drug ...

Notebook page with text MEDICARE, on a table with a stethoscope and pen, medical concept. A group of Democratic senators introduced a new bill on Thursday that would create a $5,000 cap on ...